Alexander C Ford Selected Research

Hepatic Encephalopathy

1/2016	Rifaximin for the treatment of diarrhea-predominant irritable bowel syndrome.
9/2011	Losses to follow-up limit conclusions regarding the efficacy of branched-chain amino acids in patients with hepatic encephalopathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alexander C Ford Research Topics

Disease

57	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 03/2024 - 11/2008
27	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2023 - 01/2011
19	Constipation 01/2023 - 02/2011
17	Ulcerative Colitis 01/2023 - 06/2010
16	Abdominal Pain (Pain, Abdominal) 11/2023 - 11/2008
15	Dyspepsia (Indigestion) 01/2022 - 12/2005
14	Crohn Disease (Crohn's Disease) 10/2023 - 12/2010
12	Diarrhea 12/2023 - 08/2014
7	Pain (Aches) 12/2021 - 01/2015
6	Infections 05/2024 - 08/2013
6	Opioid-Induced Constipation 01/2023 - 10/2013
6	Stomach Neoplasms (Stomach Cancer) 01/2022 - 08/2011
6	Neoplasms (Cancer) 09/2020 - 07/2015
6	Inflammation (Inflammations) 01/2018 - 04/2016
5	Gastroesophageal Reflux (GERD) 01/2023 - 11/2011
5	Necrosis 12/2021 - 08/2011
5	Peptic Ulcer (Peptic Ulcers) 01/2017 - 09/2004
3	Nausea 01/2023 - 12/2018
3	Gastroparesis 01/2023 - 11/2018
3	Celiac Disease (Celiac Sprue) 01/2017 - 04/2009
2	Fatigue 10/2023 - 01/2021
2	Herpes Zoster 01/2023 - 08/2013
2	Proctitis 07/2021 - 05/2012
2	Clostridium Infections 11/2019 - 01/2019
2	Hypersensitivity (Allergy) 01/2017 - 01/2016
2	Ulcer 04/2016 - 09/2004
2	Hepatic Encephalopathy 01/2016 - 09/2011
2	Fistula 12/2014 - 04/2011
1	Food Intolerance 05/2024
1	Calcific Pancreatitis 12/2023
1	Vomiting 01/2023
1	Fecal Incontinence 01/2023
1	Disease Progression 01/2022
1	Proctocolitis (Hemorrhagic Proctocolitis) 07/2021
1	Sarcopenia 01/2021
1	Obesity 01/2021

Drug/Important Bio-Agent (IBA)

10	Infliximab (Remicade)FDA Link 09/2021 - 03/2012
9	Antidepressive Agents (Antidepressants)IBA 01/2024 - 08/2012
9	Anti-Bacterial Agents (Antibiotics)IBA 06/2023 - 08/2010
7	Bile Acids and Salts (Bile Acids)IBA 12/2023 - 05/2015
6	Mesalamine (Mesalazine)FDA LinkGeneric 02/2023 - 12/2010
6	Neurotransmitter Agents (Neurotransmitter)IBA 12/2021 - 01/2017
6	Leukocyte L1 Antigen Complex (Calgranulin)IBA 03/2020 - 01/2011
6	Proton Pump InhibitorsIBA 12/2018 - 03/2008
5	Ondansetron (Zofran)FDA LinkGeneric 01/2023 - 07/2015
5	peppermint oilIBA 10/2022 - 11/2008
5	Rifaximin (L 105)FDA Link 01/2020 - 04/2011
5	Biomarkers (Surrogate Marker)IBA 01/2017 - 05/2014
4	linaclotideIBA 01/2023 - 11/2013
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 03/2007
4	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 01/2020 - 11/2013
4	Parasympatholytics (Antispasmodics)IBA 01/2020 - 11/2008
4	AcidsIBA 01/2019 - 03/2008
3	MonosaccharidesIBA 05/2024 - 01/2018
3	Amitriptyline (Elavil)FDA LinkGeneric 01/2024 - 07/2022
3	Opioid Analgesics (Opioids)IBA 10/2023 - 07/2013
3	Phenobarbital (Luminal)FDA Link 01/2023 - 05/2014
3	C-Reactive ProteinIBA 01/2021 - 10/2016
3	Lubiprostone FDA Link 11/2019 - 07/2015
3	Adalimumab (Humira)FDA Link 05/2015 - 08/2011
3	Azathioprine (Imuran)FDA LinkGeneric 02/2015 - 12/2010
2	Glutens (Glutelin)IBA 05/2024 - 01/2018
2	OligosaccharidesIBA 05/2024 - 01/2022
2	DisaccharidesIBA 05/2024 - 01/2022
2	tofacitinibIBA 01/2023 - 12/2021
2	cyclo(Arg-Pro) (CI 4)IBA 01/2022 - 05/2015
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 05/2021 - 04/2011
2	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2020 - 01/2014
2	tegaserod (Zelnorm)FDA Link 01/2020 - 11/2019
2	mizagliflozinIBA 11/2019 - 01/2019
2	Imipramine (Janimine)FDA LinkGeneric 12/2018 - 01/2016
2	PrebioticsIBA 11/2018 - 10/2014
2	Serotonin (5 Hydroxytryptamine)IBA 03/2018 - 10/2016
2	Buspirone (Buspar)FDA LinkGeneric 03/2018 - 11/2013
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2017 - 08/2011
2	AntibodiesIBA 08/2013 - 04/2009
2	Dihydrotachysterol (AT 10)IBA 06/2012 - 03/2007
1	AntigensIBA 05/2024
1	SalicylatesIBA 05/2024
1	Immunoglobulin G (IgG)IBA 05/2024
1	Histamine (Histamine Dihydrochloride)FDA Link 03/2024
1	ebastine (Kestin)IBA 02/2024
1	Metoclopramide (Reglan)FDA LinkGeneric 01/2023
1	Janus Kinase InhibitorsIBA 01/2023
1	CannabinoidsIBA 01/2023
1	Dopamine AntagonistsIBA 01/2023
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2022
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021
1	Magnesium Oxide (Magnesia)FDA Link 01/2021
1	Prednisolone (Predate)FDA LinkGeneric 01/2021
1	SolutionsIBA 01/2021
1	Angiotensin Receptor AntagonistsIBA 01/2021

Therapy/Procedure

55	Therapeutics 11/2023 - 09/2004
8	Biological Therapy 01/2023 - 04/2011
4	Colectomy 05/2021 - 05/2015
3	Drug Therapy (Chemotherapy) 01/2021 - 04/2016
2	Activities of Daily Living (ADL) 01/2022 - 01/2022
2	Cholecystectomy 01/2019 - 09/2015
2	Gluten-Free Diet 01/2018 - 01/2017
1	Remission Induction 10/2023